REPORTING OF TRANSACTIONS IN ORPHAZYME'S SHARES MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Copenhagen, Denmark, March 5, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by closely associated persons to persons discharging managerial responsibilities in Orphazyme:

1 Details of the Reporting Person / Closely Associated Person

a) Name

GFD Investments LLC

2 Reason for the notification

a) Position/status

Closely associated person to Georges Gemayel, Chairman of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Purchase of shares

c) Price(s) and volume(s)

Price (s)
Volume(s)

DKK 48.80

525

DKK 48.80

19

DKK 48.80

643

DKK 48.80

180

DKK 49.00

40

DKK 49.00

874

DKK 48.05

289

DKK 47.00

1,989

DKK 50.00

520

DKK 50.00

1,000

DKK 50.00

225

DKK 50.00

70

DKK 49.00

427

DKK 49.50

126

DKK 49.90

700

DKK 50.00

363

DKK 49.00

895

DKK 49.90

212

DKK 49.90

501

DKK 49.85

2

d)

Aggregated information

  • Aggregated volume

  • Price

Aggregated volume: 9,600

Price: DKK 48.8946

e) Date of the transaction

2019-03-04 – between 10:00 and 13:00 UTC-time

f) Place of the transaction

Nasdaq Copenhagen A/S - XCSE